GlassScriptPhysician profile
Jamie L Harrelson
NPI 1003338195
$4,433.13
in general payments reported to CMS, 2019-2025
38 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $941 · 2022: $1,191 · 2023: $1,293 · 2024: $664 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,301.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $603.52 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $546.98 | 2022-2025 | |
| Lilly USA, LLC | $390.96 | 2021-2025 | Mounjaro, Zepbound, Emgality |
| Abbott Laboratories | $300.88 | 2021-2024 | Freestyle Libre 3 |
| Amgen INC. | $287.82 | 2021-2025 | Otezla, Repatha, Evenity |
| Pfizer INC. | $238.88 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $180.22 | 2021-2025 | Synjardy, Jardiance, Tradjenta |
| Glaxosmithkline, LLC. | $163.67 | 2021-2024 | Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $139.92 | 2021-2023 | Farxiga, Breztri |
| Antares Pharma, INC. | $132.51 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Esperion Therapeutics, INC. | $122.15 | 2021-2023 | Nexletol |
| Baxter Healthcare | $112.17 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $101.39 | 2021-2023 | Xifaxan, Trulance |
| Biohaven Pharmaceutical Holding Company LTD. | $94.01 | 2022 | |
| Neurocrine Biosciences, INC. | $85.68 | 2025 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Harrelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.